Sino Biological Inc

Ziath

Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 Initiates in Taiwan

The first volunteers have been safely dosed in COVAXX's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan.

New Collaboration Explores Efficacy of Gene Delivery Vector Tech in Diabetes and Multiple Sclerosis

Amarna Therapeutics has announced today that it has entered into a collaboration with scientists from the Progreso y Salud Foundation (FPS) at Cabimer in Seville, to jointly examine the efficacy of Amarna’s SVec™ gene delivery vector for the development of effective immunotherapies for diabetes mellitus type 1 (DM1) and multiple sclerosis (MS).

First Data on Using a Therapeutic Form of ACE2 To Treat COVID-19 Published

A case report published today in The Lancet Respiratory Medicine outlines the first compassionate use of recombinant soluble human ACE2 (APN01) to treat a female 45-year-old patient who was diagnosed with severe COVID-19.

Solus Listeria monocytogenes ELISA Assay for Testing Across Food and Environmental Samples

PerkinElmer is a global leader committed to innovating for a healthier world. On September 21st, 2020 they launched the PerkinElmer Solus Listeria monocytogenes ELISA Assay. This new offering will help high throughput food processors and contract labs focus on L. mono testing for food and environmental surface samples.